MR Imaging-Verified Plaque Delipidation With Lipid-Lowering Therapy
Author(s) -
Christopher M. Kramer,
Venkatesh Mani,
Zahi A. Fayad
Publication year - 2011
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2011.06.014
Subject(s) - medicine , cardiology , stroke (engine) , surrogate endpoint , cholesterol , radiology , physics , thermodynamics
Numerous studies over the past 2 decades have demonstrated the benefit of low-density lipoprotein (LDL) cholesterol lowering on heart attack, stroke, and cardiac death ([1][1]). Both invasive and noninvasive imaging approaches have been used as surrogate markers to demonstrate benefits of LDL
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom